MedFirst Healthcare Services, Inc. (TPEX:4175)
50.20
+0.20 (0.40%)
Jul 21, 2026, 1:18 PM CST
TPEX:4175 Revenue
MedFirst Healthcare Services had revenue of 1.89B TWD in the quarter ending March 31, 2026, a decrease of -0.67%. This brings the company's revenue in the last twelve months to 8.00B, up 2.61% year-over-year. In the year 2025, MedFirst Healthcare Services had annual revenue of 8.01B with 3.60% growth.
Revenue (ttm)
8.00B
Revenue Growth
+2.61%
P/S Ratio
0.27
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.12B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.01B | 278.57M | 3.60% |
| Dec 31, 2024 | 7.73B | 287.90M | 3.87% |
| Dec 31, 2023 | 7.45B | 222.11M | 3.07% |
| Dec 31, 2022 | 7.22B | 683.79M | 10.46% |
| Dec 31, 2021 | 6.54B | 612.84M | 10.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 17.50B |
| Dynamic Medical Technologies | 1.38B |
| Allied Biotech | 880.06M |
| Johnson Chemical Pharmaceutical Works | 569.57M |
| HeXun Biosciences | 293.23M |
| G&E Herbal Biotechnology | 261.21M |
| Caliway Biopharmaceuticals | 38.04M |
| Pell Bio-Med Technology | 25.85M |